Free Trial
NYSEARCA:BBC

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News

$24.20 -0.40 (-1.63%)
As of 09/10/2025 04:10 PM Eastern

About Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)

Key Stats

Today's Range
$24.15
$24.70
50-Day Range
$19.99
$24.60
52-Week Range
$13.42
$31.65
Volume
8,821 shs
Average Volume
43,205 shs
Market Capitalization
$16.94 million
Assets Under Management
$16.01 million
Dividend Yield
0.95%
Net Expense Ratio
0.79%
Aggregate Rating
Moderate Buy

ETF Overview

Virtus LifeSci Biotech Clinical Trials ETF Expenses

TypeBBCHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.79%0.56%0.56%0.51%0.53%
Other Expenses0.00%0.47%0.56%0.59%0.56%
Total Expense0.79%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.79%0.60%0.63%0.58%0.60%
Receive BBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BBC ETF News Headlines

The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC
BBC Virtus LifeSci Biotech Clinical Trials ETF
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Tech ETFs on the Rise After Four Weeks in Deep Red
See More Headlines

BBC ETF - Frequently Asked Questions

Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $23.94 at the beginning of 2025. Since then, BBC stock has increased by 1.1% and is now trading at $24.20.

Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Clinical Trials ETF investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), Meta Platforms (META), e.l.f. Beauty (ELF) and GE Aerospace (GE).

Fund Details

Issuer
Virtus
Fund Name
Virtus LifeSci Biotech Clinical Trials ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:BBC
Inception Date
12/16/2014
Fund Manager
Matthew B. Brown, Seth Kadushin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
LifeSci Biotechnology Clinical Trials Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
118

Fund Statistics

Assets Under Management
$16.01 million
Average Daily Volume
$13.40 thousand
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
Virtus ETF Solutions, LLC
Advisor
Virtus ETF Advisers, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
ETF Distributors LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
1
Put Options
1
Call Options
1
Short Interest
17,900 shs

Miscellaneous

Beta
1.08
Creation Unit
50,000
Creation Fee
$500.00
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Top 10 BBC Holdings

BBC Sector Exposure

BBC Industry Exposure


This page (NYSEARCA:BBC) was last updated on 9/11/2025 by MarketBeat.com Staff
From Our Partners